TCG Crossover Management, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1839948 PALO ALTO, CA

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$110,209,680

+$5,290,065 QoQ

Shares Held

11,020,968

0.0% QoQ

Ownership

4.31%

of shares outstanding

% of Portfolio

2.65%

of 13F equity value

Holder Rank

of 316 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TCG Crossover Management, LLC holds $234,536,030 across 3 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (47.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMLX	Amylyx Pharmaceuticals, Inc.	6,243,812	$112,138,863
2	BCRX	Biocryst Pharmaceuticals Inc This page	11,020,968	$110,209,680
3	ADCT	ADC Therapeutics SA	11,390,175	$12,187,487

All Filings in BCRX

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$110,209,680	11,020,968	0.0%	Shares	Sole	2026-08-14
2026-03-31	$104,919,615	11,020,968	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.